Abbott Labs unit recalls 2 COVID lab test kits over false positive results

An overflow of one patient sample into another while mixing chemicals with the samples could be related to the false positive results, the FDA said on Thursday.

Published On 2021-10-16 07:30 GMT   |   Update On 2021-11-17 11:43 GMT
Advertisement

New Delhi: A unit of Abbott Laboratories is recalling two COVID-19 laboratory test kits as they can potentially issue false positive results, the U.S. Food and Drug Administration (FDA) said on Thursday. 

The regulator has identified the recall of the Alinity m SARS-CoV-2 AMP and the Alinity m Resp-4-Plex AMP test kits by unit Abbott Molecular Inc as a Class 1 recall, the most serious type.

Advertisement

The agency in September issued a letter cautioning healthcare providers and clinical laboratories of a potential for false positive results with the two tests, and recommended they consider retesting positive patient samples with another authorized COVID-19 test.

The tests require a software, which is used at the laboratories where the samples are processed, to automate the mixing of chemicals.

An overflow of one patient sample into another while mixing chemicals with the samples could be related to the false positive results, the FDA said on Thursday.

On Sept. 2, Abbott Molecular issued a notice asking impacted customers to consider all positive COVID-19 test results presumptive until it was able to implement software updates to correct the issue at the customers' laboratory sites, according to the FDA.

The agency said no deaths or adverse health consequences have been reported from use of the tests.

Abbott has a range of FDA-authorized COVID-19 tests, including antigen, molecular and serology, which helped boost its revenue during the peak of the pandemic last year.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News